We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Review techniques to create synthetic datasets that mimic the characteristics of a real dataset but remove or obscure any private or sensitive information
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
The government will place 6 new synthetic opioids under the strictest level of control.
The Novel Psychoactive Substances Committee (NPSC) is seeking evidence for its review of the evidence of the misuse and harms of synthetic cathinones in the UK.
Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
Incident planning for potent synthetic opioids arriving into the illicit drug market.
Further information on this Centre for Defence Enterprise (CDE) competition for £1 million research funding.
The council provides leadership for the UK’s interests in the rapidly developing field of Synthetic Biology.
Summary of a rapid technology assessment (RTA) looking at synthetic genomics.
An impact story looking at how the UK and the US are bringing synthetic biology to the forefront of international collaboration.
In July 2009 the Advisory Council on the Misuse of Drugs (ACMD) provided advice on harmful synthetic compounds.
Further information on this Centre for Defence Enterprise (CDE) competition for £750,000 phase-1 research funding.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).